{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:19:19Z","timestamp":1790263159319,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI068581"],"award-info":[{"award-number":["AI068581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01 122853"],"award-info":[{"award-number":["K01 122853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM093939"],"award-info":[{"award-number":["R01 GM093939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI134384"],"award-info":[{"award-number":["R01 AI134384"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U01 GM110749"],"award-info":[{"award-number":["U01 GM110749"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,7]]},"DOI":"10.1093\/cid\/ciy453","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T07:18:34Z","timestamp":1527232714000},"page":"213-221","source":"Crossref","is-referenced-by-count":47,"title":["Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population"],"prefix":"10.1093","volume":"68","author":[{"given":"Soo-Yon","family":"Rhee","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Stanford University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Clutter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Stanford University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Jeffrey","family":"Fessel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaiser Permanente Northern California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kaiser Permanente Northern California, San Leandro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Slome","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A","family":"Pinsky","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L","family":"Marcus","sequence":"additional","affiliation":[{"name":"Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Hurley","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei L","family":"Kosakovsky Pond","sequence":"additional","affiliation":[{"name":"Department of Biology, Temple University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Shafer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Stanford University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,26]]},"reference":[{"key":"key\n\t\t\t\t2019010623581062300_CIT0001","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/496984","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis","volume":"41","author":"Sax","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA panel","volume":"37","author":"Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0003","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006","volume":"24","author":"Wheeler","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0004","unstructured":"Banaez Ocfemia MC , SaduvalaN, OsterAM, et al Transmitted HIV-1 drug resistance among men who have sex with men\u201411 U.S. jurisdictions, 2008\u20132011 [abstract 579]. In: 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3\u20136 March 2014."},{"key":"key\n\t\t\t\t2019010623581062300_CIT0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000000831","article-title":"Prevalence of transmitted HIV drug resistance among recently infected persons in San Diego, CA 1996\u20132013","volume":"71","author":"Panichsillapakit","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0006","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/ciw382","article-title":"Transmitted HIV drug resistance is high and longstanding in metropolitan Washington, DC","volume":"63","author":"Kassaye","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciu003","article-title":"A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City","volume":"58","author":"Gagliardo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13104-017-2764-9","article-title":"Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999\u20132014","volume":"10","author":"Aldous","year":"2017","journal-title":"BMC Res Notes"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/aid.2011.0022","article-title":"Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy","volume":"28","author":"Taniguchi","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0010","doi-asserted-by":"crossref","first-page":"e21189","DOI":"10.1371\/journal.pone.0021189","article-title":"Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load","volume":"6","author":"Poon","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SMJ.0b013e3181fcd75b","article-title":"Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005\u20132009","volume":"104","author":"Youmans","year":"2011","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0012","volume-title":"Similarity of the adult Kaiser Permanente membership in Northern California to the insured and general population in Northern California: statistics from the 2011 California Health Interview Survey","author":"Gordan","year":"2015"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0013","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.03.024","article-title":"Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration","volume":"18","author":"Rhee","year":"2017","journal-title":"EBioMedicine"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2014.04.001","article-title":"E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings","volume":"107","author":"Sluis-Cremer","year":"2014","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0016","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3851\/IMP2636","article-title":"96-week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE phase III trials","volume":"18","author":"Rimsky","year":"2013","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0017","doi-asserted-by":"crossref","first-page":"e0181357","DOI":"10.1371\/journal.pone.0181357","article-title":"Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation","volume":"12","author":"Paredes","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0019","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","volume":"14","author":"Ragonnet-Cronin","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-2148-7-214","article-title":"BEAST: Bayesian evolutionary analysis by sampling trees","volume":"7","author":"Drummond","year":"2007","journal-title":"BMC Evol Biol"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0021","volume-title":"Tracer: MCMC trace analysis tool. 1.5 e","author":"Rambaut","year":"2009"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0022","volume-title":"FigTree","author":"Rambaut","year":"2017"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/molbev\/msi105","article-title":"Not so different after all: a comparison of methods for detecting amino acid sites under selection","volume":"22","author":"Kosakovsky Pond","year":"2005","journal-title":"Mol Biol Evol"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.meegid.2013.03.050","article-title":"Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys","volume":"18","author":"Andersson","year":"2013","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/infdis\/jis411","article-title":"Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED","volume":"206","author":"Ragonnet-Cronin","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0026","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/cid\/ciq164","article-title":"Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection","volume":"52","author":"Kouyos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmi.2017.06.014","article-title":"Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996\u20132016","volume":"24","author":"Rocheleau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0028","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0029","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/jix015","article-title":"Commonly transmitted HIV-1 drug resistance mutations in reverse-transcriptase and protease in antiretroviral treatment-naive patients and response to regimens containing tenofovir disoproxil fumarate or tenofovir alafenamide","volume":"215","author":"Margot","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0031","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (March 2018)","author":"US Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0032","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiq167","article-title":"Differential persistence of transmitted HIV-1 drug resistance mutation classes","volume":"203","author":"Jain","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0033","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/infdis\/jit345","article-title":"Persistence of HIV-1 transmitted drug resistance mutations","volume":"208","author":"Castro","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0034","doi-asserted-by":"crossref","first-page":"e1004722","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds","volume":"11","author":"Yang","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12977-014-0105-9","article-title":"Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity","volume":"11","author":"Pingen","year":"2014","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0036","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cit694","article-title":"Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study","volume":"58","author":"Drescher","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0037","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00769-17","article-title":"No substantial evidence for sexual transmission of minority HIV drug resistance mutations in men who have sex with men","volume":"91","author":"Chaillon","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0038","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/QAD.0000000000000768","article-title":"A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK","volume":"29","author":"Mourad","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0039","doi-asserted-by":"crossref","first-page":"32251","DOI":"10.1038\/srep32251","article-title":"A direct comparison of two densely sampled HIV epidemics: the UK and Switzerland","volume":"6","author":"Ragonnet-Cronin","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019010623581062300_CIT0040","unstructured":"Hernandez AL , OcfemiaM, SaduvalaN, et al HIV integrase genotypic testing and resistance in the United States\u20149 jurisdictions [abstract 978]. In: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 13\u201316 February 2017."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/2\/213\/27407442\/ciy453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T10:48:23Z","timestamp":1571395703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/2\/213\/5005024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,26]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5,26]]},"published-print":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy453","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,15]]},"published":{"date-parts":[[2018,5,26]]}}}